LiveHealth

livehealth.in

LiveHealth enables better interaction between Healthcare Providers, Doctors and Patients on one platform making access to organised medical information easy and seamless. For Healthcare Providers, we offer Information Systems (IS) for Diagnostics & Laboratories, which make medical information management easier, seamless and mobile without the overheads of IT Infrastructure and development. We help you grow easily, scale to multiple locations with just a few clicks and monitor and manage your operations in real time, right from your mobile.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

MEDICAL

LIGHT BIO PARTNERS WITH GINKGO BIOWORKS TO OPTIMIZE THE BRIGHTNESS OF GLOWING PLANTS THROUGH BIOLUMINESCENCE ENGINEERING

Light Bio | April 18, 2022

news image

Light Bio, Inc., a company that is creating bioluminescent plants for home and garden, and Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, today announced a collaboration to leverage Ginkgo's plant cell assays for bioluminescence engineering. Through the agreement, Ginkgo aims to help improve the luminescent output and efficiency of the enzymes within Light Bio's glowing ornamental plants. The scientists at Light Bio have discovered a new...

Read More

MEDICAL

NIKANG THERAPEUTICS COMPLETES $200 MILLION SERIES C FINANCING TO ADVANCE HIGHLY DIFFERENTIATED SMALL MOLECULES ADDRESSING DIFFICULT-TO-DRUG TARGETS

NiKang Therapeutics | May 31, 2021

news image

NiKang Therapeutics Inc., a clinical-stage biotech company focused on developing innovative small molecule oncology medicines to assist patients with unmet medical needs; today announced the completion of an oversubscribed $200 million Series C financing led by Cormorant Asset Management, HBM Healthcare Investments, and Octagon Capital Advisors with participation from a premier syndicate of funds, including new investors EcoR1 Capital, Perceptive Advisors, Wellington Management, Ally Bridge Grou...

Read More

INDUSTRIAL IMPACT

ACTIVE MOTIF AND EPICYPHER EXECUTE CROSS-LICENSING AGREEMENT AND END ONGOING LITIGATION INVOLVING TARGETED TRANSPOSITION TECHNOLOGY FOR EPIGENOMICS

EpiCypher and Active Motif | August 01, 2022

news image

CUT&Tag is a targeted transposition technique that allows high-resolution genomic mapping of histone modifications and chromatin-associated proteins through the precise insertion of DNA sequences into the genome using the Tn5 transposase enzyme. EpiCypher and Active Motif each own or control patents covering complementary aspects of targeted transposition. Active Motif and EpiCypher have leveraged their respective IP to independently create successful genomic mapping tools tha...

Read More

CELL AND GENE THERAPY

VIPERGEN PUBLISHES POWERFUL NEW DRUG DISCOVERY APPROACH FOR THE FIRST TIME, SCREENING DNA-ENCODED SMALL-MOLECULE LIBRARIES (DELS) INSIDE LIVING CELLS

Vipergen | February 18, 2021

news image

Vipergen ApS announced today a published study depicting a ground-breaking new medication revelation approach that empowers, interestingly, screening DNA-encoded small-molecule libraries (DELs) inside living cells. The study, published in the peer-reviewed Journal of the American Chemical Society, highlights the potential of Vipergen's Cellular Binder Trap Enrichment® (cBTE) technology to significantly grow the ability to discover novel small molecules, including against difficult-to-dru...

Read More
news image

MEDICAL

LIGHT BIO PARTNERS WITH GINKGO BIOWORKS TO OPTIMIZE THE BRIGHTNESS OF GLOWING PLANTS THROUGH BIOLUMINESCENCE ENGINEERING

Light Bio | April 18, 2022

Light Bio, Inc., a company that is creating bioluminescent plants for home and garden, and Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, today announced a collaboration to leverage Ginkgo's plant cell assays for bioluminescence engineering. Through the agreement, Ginkgo aims to help improve the luminescent output and efficiency of the enzymes within Light Bio's glowing ornamental plants. The scientists at Light Bio have discovered a new...

Read More
news image

MEDICAL

NIKANG THERAPEUTICS COMPLETES $200 MILLION SERIES C FINANCING TO ADVANCE HIGHLY DIFFERENTIATED SMALL MOLECULES ADDRESSING DIFFICULT-TO-DRUG TARGETS

NiKang Therapeutics | May 31, 2021

NiKang Therapeutics Inc., a clinical-stage biotech company focused on developing innovative small molecule oncology medicines to assist patients with unmet medical needs; today announced the completion of an oversubscribed $200 million Series C financing led by Cormorant Asset Management, HBM Healthcare Investments, and Octagon Capital Advisors with participation from a premier syndicate of funds, including new investors EcoR1 Capital, Perceptive Advisors, Wellington Management, Ally Bridge Grou...

Read More
news image

INDUSTRIAL IMPACT

ACTIVE MOTIF AND EPICYPHER EXECUTE CROSS-LICENSING AGREEMENT AND END ONGOING LITIGATION INVOLVING TARGETED TRANSPOSITION TECHNOLOGY FOR EPIGENOMICS

EpiCypher and Active Motif | August 01, 2022

CUT&Tag is a targeted transposition technique that allows high-resolution genomic mapping of histone modifications and chromatin-associated proteins through the precise insertion of DNA sequences into the genome using the Tn5 transposase enzyme. EpiCypher and Active Motif each own or control patents covering complementary aspects of targeted transposition. Active Motif and EpiCypher have leveraged their respective IP to independently create successful genomic mapping tools tha...

Read More
news image

CELL AND GENE THERAPY

VIPERGEN PUBLISHES POWERFUL NEW DRUG DISCOVERY APPROACH FOR THE FIRST TIME, SCREENING DNA-ENCODED SMALL-MOLECULE LIBRARIES (DELS) INSIDE LIVING CELLS

Vipergen | February 18, 2021

Vipergen ApS announced today a published study depicting a ground-breaking new medication revelation approach that empowers, interestingly, screening DNA-encoded small-molecule libraries (DELs) inside living cells. The study, published in the peer-reviewed Journal of the American Chemical Society, highlights the potential of Vipergen's Cellular Binder Trap Enrichment® (cBTE) technology to significantly grow the ability to discover novel small molecules, including against difficult-to-dru...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us